10,851 reports of this reaction
2.6% of all PANTOPRAZOLE SODIUM reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for PANTOPRAZOLE SODIUM, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 10,851 FDA adverse event reports linking PANTOPRAZOLE SODIUM to FATIGUE. This represents approximately 2.6% of all 411,823 adverse event reports for this drug.
PANTOPRAZOLE SODIUM has an overall safety score of 85 out of 100. Patients taking PANTOPRAZOLE SODIUM who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for PANTOPRAZOLE SODIUM, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for PANTOPRAZOLE SODIUM:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 10,851 FDA reports for PANTOPRAZOLE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.6% of all adverse event reports for PANTOPRAZOLE SODIUM, making it one of the most commonly reported side effect.
If you experience fatigue while taking PANTOPRAZOLE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.